MDXH
MDxHealth S.A. NASDAQ Listed Nov 4, 2021$0.43
-6.12%
vs $0.45
Mkt Cap $21.4M
52w Low $0.43
0.0% of range
52w High $5.00
50d MA $1.22
200d MA $3.02
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-7.9x
ROE
—
P/FCF
-1.8x
RSI (14)
31.20
ATR (14)
$0.05
Beta
0.38
50d MA
$1.22
200d MA
$3.02
Avg Volume
1.2M
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
CAP Business Center · Herstal, C9 4040 · BE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.13 | -0.17 | -30.8% | 3.55 | +1.1% | -4.2% | -0.9% | -0.6% | +2.1% | -3.2% | — |
| Nov 12, 2025 | AMC | -0.12 | -0.16 | -33.3% | 4.12 | -0.2% | -3.6% | -8.3% | -11.8% | +0.0% | +1.6% | — |
| Aug 5, 2025 | AMC | -0.13 | -0.15 | -15.4% | 2.49 | +4.8% | +10.4% | -1.8% | -1.5% | +8.3% | -0.3% | — |
| May 14, 2025 | AMC | -0.13 | -0.19 | -46.2% | 1.78 | -3.9% | +6.7% | +10.0% | -1.0% | +4.3% | -3.2% | — |
| Feb 26, 2025 | AMC | -0.21 | -0.14 | +33.3% | 1.83 | +2.2% | +1.6% | -2.2% | -6.0% | -4.1% | -4.9% | — |
| Aug 21, 2024 | AMC | -0.26 | -0.31 | -19.2% | 3.27 | +0.0% | -12.2% | +0.0% | -3.5% | +5.8% | -2.4% | — |
| May 1, 2024 | AMC | -0.30 | -0.31 | -3.3% | 2.67 | +2.2% | +11.2% | +5.7% | -0.3% | -0.6% | -3.5% | — |
| Mar 6, 2024 | AMC | -0.11 | -0.39 | -254.5% | 3.73 | +2.9% | -17.4% | -3.6% | -4.0% | -8.8% | +10.0% | — |
| Nov 8, 2023 | AMC | -0.31 | -0.40 | -29.0% | 3.10 | -2.6% | -14.2% | +6.0% | +13.5% | -3.4% | +1.0% | — |
| Aug 23, 2023 | AMC | -0.32 | -0.30 | +6.2% | 3.68 | -0.3% | -6.0% | -9.8% | -4.2% | +0.7% | +1.0% | — |
| May 15, 2023 | AMC | -0.40 | -0.05 | +87.5% | 3.68 | +6.0% | +14.1% | -6.2% | +0.3% | -2.8% | -1.8% | — |
| Mar 8, 2023 | AMC | -0.75 | -1.10 | -46.7% | 3.69 | +0.8% | -10.6% | -10.6% | -11.5% | +5.4% | -1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 | William Blair | Downgrade | Outperform → Mkt Perform | — | $1.95 | $1.07 | -45.1% | -49.5% | -9.3% | -4.9% | -1.1% | +4.8% |
| Dec 23 | BTIG | Maintains | Buy → Buy | — | $3.40 | $3.42 | +0.6% | +2.1% | +0.0% | -1.7% | -1.8% | +4.8% |
| Nov 13 | Lake Street | Maintains | Buy → Buy | — | $4.12 | $4.11 | -0.2% | -3.6% | -8.3% | -11.8% | +0.0% | +1.6% |
| Nov 13 | TD Cowen | Maintains | Buy → Buy | — | $4.12 | $4.11 | -0.2% | -3.6% | -8.3% | -11.8% | +0.0% | +1.6% |
| Nov 13 | BTIG | Maintains | Buy → Buy | — | $4.12 | $4.11 | -0.2% | -3.6% | -8.3% | -11.8% | +0.0% | +1.6% |
| Nov 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.08 | $2.12 | +1.9% | +0.5% | -2.9% | -2.5% | -3.5% | -5.8% |
| Mar 7 | BTIG | Maintains | Buy → Buy | — | $3.73 | $3.84 | +2.9% | -17.4% | -3.6% | -4.0% | -8.8% | +10.0% |
| Mar 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.73 | $3.84 | +2.9% | -17.4% | -3.6% | -4.0% | -8.8% | +10.0% |
| Nov 9 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.10 | $3.02 | -2.6% | -14.2% | +6.0% | +13.5% | -3.4% | +1.0% |
| Jun 20 | BTIG | Maintains | Buy → Buy | — | $3.71 | $3.67 | -1.1% | -1.3% | -4.9% | -0.3% | -2.9% | -4.2% |
| May 31 | TD Cowen | Maintains | Outperform → Outperform | — | $3.59 | $3.59 | +0.0% | +1.4% | +4.4% | +6.1% | -3.5% | +2.6% |
| May 15 | BTIG | Maintains | Buy → Buy | — | $3.71 | $3.71 | +0.0% | -0.8% | +14.1% | -6.2% | +0.3% | -2.8% |
| Apr 19 | BTIG | Maintains | Buy → Buy | — | $3.35 | $3.27 | -2.4% | -0.3% | +15.0% | +3.1% | +2.8% | -2.7% |
| Mar 24 | William Blair | Maintains | Outperform → Outperform | — | $2.86 | $2.87 | +0.3% | -0.3% | +0.0% | +6.3% | +5.0% | -0.9% |
| Mar 8 | BTIG | Maintains | Buy → Buy | — | $3.74 | $3.74 | +0.0% | -1.3% | -10.6% | -10.6% | -11.5% | +5.4% |
| Mar 5 | Piper Sandler | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Nov 8 | BTIG | Maintains | Buy → Buy | — | $7.26 | $7.37 | +1.5% | +2.1% | -0.5% | +1.9% | +1.1% | +4.2% |
| Oct 30 | BTIG | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Aug 25 | BTIG | Maintains | Buy → Buy | — | $8.29 | $8.79 | +6.0% | -1.2% | -2.9% | +0.9% | +3.5% | -4.0% |
| Nov 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.04 | $10.00 | +10.6% | +2.1% | -1.6% | +2.9% | -1.6% | -0.3% |
| Nov 29 | Oppenheimer | Maintains | Outperform → Outperform | — | $9.04 | $10.00 | +10.6% | +2.1% | -1.6% | +2.9% | -1.6% | -0.3% |
| Nov 29 | BTIG | Maintains | Buy → Buy | — | $9.04 | $10.00 | +10.6% | +2.1% | -1.6% | +2.9% | -1.6% | -0.3% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Small Cap Core Fund | 57,475 | $132K | Mar 2026 |
Valuation
Market Cap
$21.4M
Enterprise Value
$77.0M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.38x
P/B
—
P/S
0.12x
P/FCF
-1.84x
EV/EBITDA
—
Shares Out
50.0M
Financials (TTM)
Revenue
$171.3M
Net Income
-$64.2M
EBITDA
-$21.1M
Free Cash Flow
-$11.6M
Op Cash Flow
-$10.4M
EPS Basic
$-0.67
EPS Diluted
$-1.78
EPS Forward
$-0.39
Gross Margin
59.6%
Op Margin
-22.3%
Net Margin
-37.5%
Balance Sheet
Total Assets
$148.0M
Total Liab.
$160.0M
Total Equity
-$12.1M
Cash
$29.0M
LT Debt
$84.7M
Book Value/Sh
$-0.24
Debt/Equity
-7.86x
Current Ratio
1.08
Quick Ratio
0.94
Returns & Growth
ROE
—
ROA
—
ROIC
-14.5%
Rev Growth YoY
+19.8%
EPS Growth YoY
+14.1%
Price Returns
2W
-27.3%
1M
-62.8%
3M
-77.7%
6M
-79.4%
12M
-64.0%
Technicals
52W High
$5.00
52W Low
$0.43
50d MA
$1.22
200d MA
$3.02
RSI (14)
31.20
ATR (14)
$0.05
Beta
0.38
Avg Volume
1.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$15.00
High
$15.00
Low
$15.00
Median
$15.00
Data updated apr 26, 2026 11:46am
· Source: financialmodelingprep.com